Glucophage® Extended Release (XR) 750 Milligram (mg) Indonesia Bioequivalence (BE) Study
Clinical trial NCT03583385 · COMPLETED
Trial details
- NCT number
- NCT03583385
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-16
- Primary completion
- 2018-10-05
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.